Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 151
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin degludec
  • Huntsville, Alabama
  • +85 more
Dec 7, 2018

Diabetes, Type 2, Albuminuria Trial in Worldwide (Placebo, Canagliflozin, 100 mg, Canagliflozin, 300 mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Albuminuria
  • Placebo
  • +2 more
  • Little Rock, Arkansas
  • +353 more
Nov 19, 2018

Diabetes, Type 2 Trial in Worldwide (Bolus Insulin Patch (Calibra Finesse), Insulin Pen (Novo-Nordisk FlexPen®))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Bolus Insulin Patch (Calibra Finesse)
  • Insulin Pen (Novo-Nordisk FlexPen®)
  • Phoenix, Arizona
  • +51 more
Nov 6, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +105 more
Sep 3, 2018

Diabetes, Type 2 Trial in Worldwide (Insulin glargine, 300U/mL, Insulin degludec, 100 U/mL, Non-insulin anti-diabetic treatment)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300U/mL
  • +2 more
  • Sheffield, Alabama
  • +157 more
Aug 14, 2018

Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Hueytown, Alabama
  • +102 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in United States (pioglitazone, inhaled human insulin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ozark, Alabama
  • +109 more
Sep 3, 2018

Diabetes, Type 2, Hypertension Trial in United States (Empagliflozin low dose, , Empagliflozin high dose)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Hypertension
  • Empagliflozin low dose
  • +2 more
  • Birmingham, Alabama
  • +91 more
Jul 4, 2018

Diabetes, Type 2 Trial in United States (Exenatide once weekly suspension, Exenatide twice daily)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Exenatide once weekly suspension
  • Exenatide twice daily
  • Muscle Shoals, Alabama
  • +57 more
Jun 4, 2018

Diabetes, Type 2 Trial in Worldwide (GSK523338)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +84 more
Apr 2, 2018

Diabetes, Type 2 Trial in Worldwide (LY2605541, Human Insulin NPH, Oral Antihyperglycemic Medications (OAM))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Tempe, Arizona
  • +62 more
May 1, 2018

Diabetes, Type 2 Trial in Worldwide (LY2605541, Insulin glargine)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +60 more
Mar 17, 2018

Diabetes, Type 2 Trial in Worldwide (Glargine, LY2605541)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +166 more
Mar 16, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, insulin degludec, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/insulin aspart
  • +2 more
  • Greenbrae, California
  • +50 more
Mar 6, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Tuscumbia, Alabama
  • +116 more
Mar 1, 2018

Diabetes, Type 2 Trial in Worldwide (Placebo, DEN 2.5 mg, DEN 7.5 mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Placebo
  • +5 more
  • Long Beach, California
  • +108 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (rosiglitazone maleate/metformin HCl)

Completed
  • Diabetes Mellitus, Type 2
  • rosiglitazone maleate/metformin hydrochloride
  • Anniston, Alabama
  • +101 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (rosiglitazone/metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +93 more
Mar 19, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +301 more
Feb 16, 2018

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, glyburide, metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +489 more
Nov 27, 2017

Diabetes, Type 2 Trial in Worldwide (GSK189075, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +156 more
Sep 26, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, , liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Anaheim, California
  • +131 more
Aug 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • Hamilton, Alabama
  • +83 more
Apr 24, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin Degludec, Insulin Glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin Degludec
  • Insulin Glargine
  • Anaheim, California
  • +80 more
Mar 9, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (FlexTouch®, FlexPen®)

Completed
Has Results
  • Diabetes
  • +3 more
  • FlexTouch®
  • FlexPen®
  • Burlingame, California
  • +64 more
Feb 6, 2017